Stem Cell Therapeutics - News & Events


	PRESS RELEASES EVENTS PRESENTATIONS

PRESS RELEASES

Currently Viewing:


May 16, 2013	Stem Cell Therapeutics Announces Completion of Dosing in Phase I Study of TTI-1612 in Patients With Interstitial Cystitis/Bladder Pain Syndrome
May 16, 2013	Stem Cell Therapeutics to Begin Trading on the U.S. OTCQX Marketplace
Apr 17, 2013	Stem Cell Therapeutics Licenses Exclusive Rights to Clinical Cancer Stem Cell Program
Apr 09, 2013	Stem Cell Therapeutics Completes Trillium Merger and Issues Stock Options
Mar 28, 2013	Stem Cell Therapeutics Provides Corporate Update on Acquisitions and Financing
Mar 15, 2013	Stem Cell Therapeutics Closes $3.1 Million Financing
Mar 12, 2013	Stem Cell Therapeutics Announces Filing of Prospectus Supplement for Proceeds up to $3.5 Million of Units
Mar 07, 2013	Stem Cell Therapeutics Announces Offering of up to $3.5 million of Units
Feb 19, 2013	Stem Cell Therapeutics Announces Joint-Venture Agreement with Renu Inc. and Nexgen Medical Systems, Inc
Feb 19, 2013	Stem Cell Therapeutics Announces Proposed Offering of Units

STOCK QUOTE


Symbol:	TSX:SSS
Last Trade:	0.155
Change:	-3.12%
Volume:	2204875
Date:	5/17/2013
Time:	3:59pm
Note: Quotes are delayed. For informational purposes only.

©2004 - 2013 Stem Cell Therapeutics - All rights reserved

Home | Site Map | Terms Of Use | Contact Us